All articles by  

  1. Specialised Therapeutics to commercialise Puma’s Nerlynx for breast cancer

    International biopharmaceutical company Specialised Therapeutics has signed an agreement to commercialise Puma Biotechnology’s Nerlynx (neratinib) throughout South East Asia for…
    Read More…

    27 Nov
  2. Acerus grants Apsen rights to market Natesto in Brazil

    Canadian firm Acerus Pharmaceuticals has signed a licence, development and supply agreement to grant Apsen Farmacêutica exclusive marketing rights for…
    Read More…

    27 Nov
  3. Lead Pharma and Sanofi collaboration for autoimmune diseases achieves third milestone

    Lead Pharma has achieved a third milestone under its research collaboration with Sanofi for the development of new therapies to…
    Read More…

    23 Nov
  4. Study finds cellular mechanisms that promote pancreatitis and pancreatic cancer

    A new study conducted by US-based Lankenau Institute for Medical Research (LIMR), part of Main Line Health, has revealed the…
    Read More…

    23 Nov
  5. Tesaro’s Zejula receives EC approval to treat ovarian cancer in Europe

    The European Commission (EC) has granted marketing authorisation for US-based biopharmaceutical company Tesaro’s Zejula (niraparib) to treat women with recurrent…
    Read More…

    22 Nov
  6. Study finds gastric treatment lansoprazole may target tuberculosis

    New research conducted by the University College London (UCL) and the London School of Hygiene & Tropical Medicine in the…
    Read More…

    22 Nov
  7. UK CMA accuses Concordia of overcharging NHS for thyroid drug

    UK regulator Competition and Markets Authority (CMA) has provisionally found that Canadian drug company Concordia overcharged the National Health Service…
    Read More…

    22 Nov
  8. Pfizer and NCCN fund new projects to improve breast cancer care

    Pfizer Global Medical Grants, in collaboration with the National Comprehensive Cancer Network’s (NCCN) Oncology Research Programme (ORP), has jointly awarded…
    Read More…

    21 Nov
  9. Samsung Bioepis’ Ontruzant acquires marketing rights for cancer in Europe

    The European Commission (EC) has granted marketing authorisation for biopharmaceutical company Samsung Bioepis’ Ontruzant for the treatment of breast and…
    Read More…

    21 Nov
  10. Study finds benzodiazepine increases mortality in Alzheimer’s patients

    A new study conducted by the University of Eastern Finland has revealed that the use of benzodiazepine and related drug…
    Read More…

    21 Nov
Close
Close
Close

Go Top